OBJECTIVES: Laser lead extraction is a challenging procedure, especially in patients with old or multiple pacemaker (PM) or implantable cardioverter defibrillator (ICD) leads. The mechanical force is a leading cause of complications during the extraction procedure. Use of new laser sheaths, which deliver a rate of 80 pulses per second, may probably reduce intraoperative adverse events by reduction of extraction force.
INTRODUCTION
The number of implanted pacemakers (PMs) and implantable cardioverter defibrillators (ICDs) has been increasing in recent years [1, 2] . This was largely driven by an aging population, as well as an expansion of indications for ICD and cardiac resynchronization therapy [3, 4] . In this context, there are also an increasing number of leads that have to be extracted for several reasons such as infection, lead dysfunction or migration or upgrade of a pre-existing system. In an aging population, more cases of lead removal have to be performed in patients with multiple and old leads. As the duration of lead implantation is a main factor for successful removal procedure, there are an increasing number of complex lead extractions. In the literature, different methods for interventional lead removal including manual traction, use of locking stylets, dilator sheaths, femoral snares or laser sheaths are described [5] [6] [7] . Especially in older leads, the use of laser sheaths enables higher procedural success rates of complete lead extraction [5] [6] [7] [8] . However, extraction of chronically implanted leads remains a difficult procedure with associated morbidity and mortality [8, 9] . The mechanical force is a leading cause of complications during removal procedures [10] . Previous published results of laser lead extraction procedures were obtained using laser sheaths delivering 40 pulses per second [5] [6] [7] [8] . The 80 Hz GlideLight laser sheath is a new extraction tool, delivering double pulses per second. This may reduce the need for mechanical force, thereby preventing intraoperative adverse events. Therefore, we investigated safety and efficacy of lead extraction using the new 80 Hz GlideLight laser sheaths.
MATERIALS AND METHODS
Between June 1999 and April 2013, 390 laser lead extractions were performed in our institution. From 1999 until 2001, the Spectranetics laser sheaths (Spectranetics Corporation, Colorado Springs, CO, USA) were used, between 2002 and 2011 SLS II sheaths (Spectranetics Corporation, Colorado Springs) were utilized. Since January 2012, the new GlideLight 80 Hz laser sheaths (Spectranetics Corporation, Colorado Springs) were used and until April 2013, 76 PM and ICD leads were treated in 38 patients with this new extraction tool. Indications for laser lead extraction were discussed in an interdisciplinary heart team, including a cardiothoracic surgeon and a cardiologist (electrophysiologist).
All procedures were performed in an operating theatre under general anaesthesia by a cardiothoracic surgeon. A radial artery line was placed in all patients and they were prepared for emergent sternotomy. An extracorporeal bypass circuit is always prepared in the OR and a transoesophageal echocardiography probe is placed to monitor for pericardial and pleural effusion. The procedure was performed by fluoroscopic guidance. A CVX-300 Excimer Laser System (Spectranetics Corporation, Colorado Springs) was used in combination with 14-or 16-French GlideLight 80 Hz laser sheaths in all the patients (Fig. 1) . The laser system provides 135-ns pulses with a wavelength of 308 nm at a repetition rate of 25-80 Hz. Indications for lead removals were pocket infection (42.1%), septicaemia or endocarditis (23.7%), lead dysfunction (31.6%) and upgrade from PM to ICD (2.6%).
Complications and procedural success were defined according to the recommendations of the North American Society of Pacing and Electrophysiology [8] . Complete success was determined as removal of all lead material from the vascular space. Partial success was defined as removal of the lead with a remaining lead portion of <4 cm, while failure of the removal procedure was determined by abandoning a lead with a length >4 cm [8] .
Statistical analysis
All data were collected into a database and retrospectively analysed. Statistical analysis was performed using SPSS 21 (SPSS, Inc., Chicago, IL, USA). Continuous values are expressed as mean ± standard deviation and categorical variables are displayed as numbers and percentages.
Follow-up
Data on procedural success rates, intra-and postoperative outcomes, as well as 30-day mortality were obtained by telephone interview or clinical visit and were collected into a database and analysed retrospectively.
RESULTS
Patients' demographics are given in Table 1 . The mean patient age was 62.0 ± 17.7 years (range 18-83), and 73.7% were male. The mean body mass index was 26.9 ± 4.6 kg/m 2 . Ejection fraction below 40% was present in 14 (36.8%) patients, and 10 (26.3%) were in New York Heart Association classification III or IV. Thirteen patients in our cohort underwent a prior median sternotomy. The lead demographics are displayed in Table 2 . A total of 98 leads were implanted in our cohort of 38 patients, of which 76 (39; 51.3% ICD and 37; 48.7% PM leads) had to be extracted. A dual-coil lead was present in 12 (15.8%) patients. Sixty-one (80.3%) active-fixation and 15 (19.7%) passive-fixation leads needed laser lead removal. Twenty-six (34.2%) leads were implanted in the atrium, while the other leads were located in the ventricle (n = 42, 55.3%) or coronary sinus (n = 8; 10.5%). The mean time from lead implantation was 96.0 ± 58.3 months (range 24-288).
Intraoperative data are given in Table 3 . The mean procedural time for laser lead extraction was 68.3 ± 27.3 min (range 35-115). The mean laser treatment time was 68.8 ± 61.6 s and a mean number of 5281.2 ± 4560.8 pulses were needed for removal. The mean fluoroscopy time was 6.7 ± 4.4 min. The mean time of hospitalization was 7.9 ± 8.8 days. 
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Procedural success
Procedural success data are given in Table 4 . A total of 76 leads, 37 (48.7%) PM and 39 (51.3%) ICD leads had to be extracted. Complete lead removal was achieved in 72 of 76 leads, corresponding to a success rate of 94.8%. Partial removal was accomplished in 2 (2.6%) leads, and failure of extraction occurred in 2 leads (2.6%). The mean time from implantation of the leads with partial removal or failure of extraction procedure was with 135.5 ± 5.2 months considerably longer compared with 93.8 ± 59.1 months in patients with successful removal (P < 0.001). The partial failure was seen in an 80-year old male patient in whom two active-fixation ICD leads ([right atrium and right ventricle] dual-coil lead) which had been implanted for 131 months could not be completely extracted due to lead breakage. Indication for device removal was recurrent pocket infection.
Complete failure of extraction occurred in one 30-year old female patient with two implanted active-fixation PM leads (RA, RV lead), which had to be extracted for pocket infection. Age of leads was 140 months. Due to strong adhesions of both leads, extraction was not possible.
Complications
No intra-or perioperative deaths occurred in any of the patients and 30-day survival was 100%. The overall complication rate was 5.2% including one major complication (2.6%) and one minor complication (2.6%). The major complication was a lateral perforation of the superior vena cava (SVC) during the lead extraction procedure in a 75-year old male patient with two active-fixation PM leads which had been implanted for 154 months. The reason for the perforation has probably been a strong adhesion of one lead to the lateral part of the SVC. After sternotomy, the SVC was successfully sutured without cardiopulmonary bypass and without further complications. Furthermore, one haematoma of the PM pocket that had to be revised surgically was the only minor complication in this series.
DISCUSSION
With the growing number of cardiac implantable electrophysiological devices (CIED), there are also an increasing number of leads that have to be extracted. Indications for lead removal are local or systemic device infections, endocarditis, lead migration or dysfunction or upgrade of an implanted system. In an aging population with a high number of multiple and old leads, extraction procedures are getting more and more challenging. Here, interventional lead removal by means of manual traction, locking stylets, dilator sheaths or femoral snares is often not possible. In these cases, laser lead extraction allows a high percentage of successful interventional lead removal procedures [10] [11] [12] [13] [14] . Besides lead extraction, further indication for Excimer laser use is the recanalization of stenotic or occluded veins, thereby facilitating new device implantation by transvenous approach to avoid open surgical treatment for epicardial lead placement [15] . In the literature, all studies of laser lead extraction procedures have been performed with use of laser sheaths with a repetition rate of 40 laser pulses per second [10-13, 16, 17] .
Mechanical force is a leading cause of complications in lead removal procedures, including vascular injury, lead uncoiling or breakage and damage, or dislodgement of adjacent leads [10, [17] [18] [19] . The new GlideLight 80 Hz laser sheaths deliver twice as many pulses per second as the SLS II 40 Hz laser sheaths. Compared with SLS II, the GlideLight 80 Hz sheaths allow the same advancement rate at half the force and facilitate 62.0% more effective advancement through tough binding sites at the same force. Although in our cohort we had a high number of patients with old leads (mean time from implantation of 96.0 ± 58.3 months), with 94.8%, the rate of complete lead removal was very high. The rate of partial success was 2.6% corresponding to two leads fragments (<4 cm) in one patient that could not be completely extracted due to lead breakage. One of the reasons for lead breakage in this case might be the age of the leads, which had been implanted for 11.7 years. A failure of extraction procedure occurred in one patient (2.6%) in whom two of four leads could not be explanted because of an impossibility to introduce the lead-locking device. In our own lead extraction experience with the SLS II laser sheaths, we had a rate of complete lead removal of 93.5% in 504 treated leads. Complete and partial failure of extraction occurred in 2.78 and 3.77%, respectively. In previous published studies, using 40 Hz laser sheaths, success rates for complete lead removal have been described between 90.0 and 96.5%. In the PLEXES trial, a large randomized trial including 301 patients, Wilkoff et al. reported a success rate of complete removal of 94.0%. In large multicentre trials by Wazni et al. [14] and Byrd et al., success rates for complete lead extractions of 96.5 and 90.0% have been reported. In these studies, failure of laser lead extraction was 1.1 and 7.0%, respectively. In our study, there was a failure rate of 2.6%. Although it is difficult to compare those results to ours, due to the limited number of patients in our cohort, the first results of laser lead extraction with GlideLight 80 Hz sheaths concerning procedural success are promising.
Occurrence of procedure-related major complications has been reported in all previous published studies of laser lead extraction. In our series with the GlideLight 80 Hz sheaths, one major complication occurred (2.6%). In our previous experience with the SLS II 40 Hz sheaths, we observed a major complication rate of 2.3% in 343 patients. This finding is consistent with other recent published data. Wilkoff et al. published a major complication rate of 2.5% in the PLEXES trial, and Kennergren published a rate of 2.0% for major complications in the European Experience of laser lead extraction. Retrospective studies by Byrd et al. revealed a major complication rate of 1.9%.
In our series with the GlideLight sheaths no intra-or perioperative death occurred within 30-day follow-up period. However, in other previous published studies of laser lead removal, death rates between 0.7 and 1.9% were reported [13, 14, [16] [17] [18] . In our opinion, it is, therefore, essential that all laser lead extractions are performed in an operating theatre with the patient prepared for emergent sternotomy and an extracorporeal bypass circuit standby. Furthermore, frequent monitoring including arterial pressure and transoesophageal echocardiography is mandatory for rapid diagnosis of any haemodynamic instability. This allows adequate management of major complications as seen in our series in the patient with perforation of the SVC. The urgent sternotomy facilitated suturing of the vascular perforation, and prevented the patient from further severe complications. Minor complication rate in our series was 2.6%, which is comparable with results of other previous published studies by Wilkoff et al. [10] and Wazni et al. [14] . Furthermore, in our own experience of lead extraction in 343 patients with SLS II sheaths, we observed a minor complication rate of 2.6%.
Similarly to the published data by Kennergren et al., we were not able to find any correlation between the size of sheaths and complication rate and we also did not observe a higher incidence of complications in ICD lead extractions.
In this study, we observed short laser and fluoroscopy times of 68.8 ± 61.6 s and 6.7 ± 4.4 min using the new GlideLight laser sheaths. This may probably result from a higher advancement rate at the same force, provided by the GlideLight 80 Hz sheaths.
Study limitations
The major limitation of this study is that we here used a retrospective data analysis. The disadvantages of a retrospective, nonrandomized study, including unknown confounders as well as selection and detection bias, cannot be completely avoided. Furthermore, this study has been a single-centre analysis including a relatively small number of patients. Therefore, in the future, larger prospective randomized trials are needed to investigate the safety and efficacy of GideLight 80 Hz laser sheaths.
CONCLUSION
In this study, the GlideLight 80 Hz laser sheath allowed safe and effective removal of chronically implanted PM and ICD leads, combining high procedural success with low complication rates.
